Karah Herdman Parschauer Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karah Herdman Parschauer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karah Herdman Parschauer. Karah Herdman Parschauer is a EVP and General Counsel in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in Evolus, Inc. ($EOLS) and a Director in Arcturus Therapeutics Holdings Inc. ($ARCT).
Address: C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO 94949 CA
Companies in which Karah Herdman Parschauer is an Insider
Arcturus Therapeutics Holdings Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: Director
Holdings: 0 shares
Latest Transaction: Jun 24 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Evolus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: Director
Holdings: 19,313 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: EVP and General Counsel
Holdings: 29,997 shares
Current Value: $2,187,081
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Karah Herdman Parschauer
Sentiment: All, ARCT, EOLS, RARE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 113.67 | 313 | 35,579 | 29,997 | 30.3 K to 30 K (-1.03 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | A | 142.47 | 11,000 | 1,567,170 | 11,000 | |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 138.17 | 3,970 | 548,535 | 30,227 | 34.2 K to 30.2 K (-11.61 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 4,636 | 0 | 34,197 | 29.6 K to 34.2 K (+15.68 %) |
| Mar 03 2021 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 5,500 | 0 | 29,561 | 24.1 K to 29.6 K (+22.86 %) |
| Feb 09 2021 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Director | Grant | A | 0.00 | 19,313 | 0 | 19,313 | 0 to 19.3 K |
| Nov 02 2020 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Option Exercise | M | 54.50 | 9,903 | 539,714 | 25,000 |